Back to search results

Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Locally Advanced Adrenal Cortex Carcinoma · Adrenal Cortical Carcinoma · Stage III Adrenal Cortex Carcinoma · Stage IV Adrenal Cortex Carcinoma AJCC v8 · Unresectable Adrenal Cortex Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Wilena Session) · wsessio@emory.edu
    Contact: Principal Investigator (Shahid S. Ahmed, MBBS)

  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Wilena Session) · wsessio@emory.edu
    Contact: Principal Investigator (Shahid S. Ahmed, MBBS)
Study leads

  • Shahid S. Ahmed, MBBS

    Principal Investigator

    Emory University Hospital/Winship Cancer Institute

View source on ClinicalTrials.gov(opens in a new tab)